Log in
Pharmacology · Cardiovascular Drugs

Captopril

Captoprilum

Captopril is historically the first angiotensin-converting enzyme (ACE) inhibitor introduced into broad clinical practice. The drug is characterized by a rapid onset of effect and a short duration of action, which requires frequent administration to maintain target blood pressure.

Onset of actionThe therapeutic effect develops rapidly — within 30–60 minutes after administration
DurationA short-acting drug, it works in the body from 4 to 8 hours
Effect of foodFood reduces absorption down to 30–55%; the administration schedule is critically important
HemodynamicsReduces preload, afterload, and total vascular resistance
4 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Pharmacokinetics and effect of food

Captopril exhibits a good degree of absorption upon entering the gastrointestinal tract. However, its pharmacokinetics has a vulnerable point — a pronounced dependence on gastric contents. If a patient takes the tablet together with food, the bioavailability of the active substance drops catastrophically: absorption decreases to 30–55%. This means that a significant portion of the dose simply will not enter the systemic circulation, leading to the absence of the expected antihypertensive response. This is precisely why physicians strictly regulate the administration schedule relative to meals.

Regarding time parameters, the drug belongs to short-acting agents. After oral administration, the onset of the therapeutic effect is registered within just 30–60 minutes. This makes it convenient for rapid blood pressure control. The flip side of the coin is the duration of action, which is limited to a time window of 4–8 hours. Due to such a short therapeutic window, frequent, multiple administrations of the medication are required to maintain a stable blood pressure profile throughout the day.

Pharmacodynamics and vascular effects

The pharmacodynamic profile of the drug is based on its ability to induce systemic vasodilation. First and foremost, a pronounced dilation of peripheral arteries occurs. This directly leads to a decrease in total peripheral vascular resistance (TPVR) — a key factor determining the level of blood pressure. In parallel, some venous dilation is observed, which increases venous capacitance.

The complex effect on the arterial and venous bed exerts a powerful positive impact on the heart. Due to venodilation, venous return to the right atrium decreases, which clinically means a reduction in preload. At the same time, the drop in TPVR facilitates blood ejection from the left ventricle, thereby reducing afterload on the myocardium.

In addition to systemic effects, the drug selectively modulates regional blood flow. Its positive impact on microcirculation has been proven: it reliably improves blood circulation in the pulmonary circulation vessels and normalizes hemodynamics in the kidneys.

Test your knowledge on the topicTasks from the «Pharmacology» course bank — instant answers and explanations.

Indications for use

Based on the described hemodynamic effects, two main points of application of the drug in clinical practice are distinguished:

  1. Arterial hypertension. The drug successfully lowers blood pressure, and it is particularly effective in patients with high-renin forms of hypertension. In such cases, the pathogenesis of the disease is closely linked to hyperactivation of the renin system, and direct ACE inhibition allows breaking this pathological cascade.
  2. Chronic heart failure (CHF). In heart failure, the myocardium cannot cope with pumping blood. The drug's ability to reduce preload and afterload significantly unloads the weakened heart muscle, improves the heart's pumping function, and optimizes circulation in the pulmonary circuit.

Side effects

Interference with complex biochemical processes inevitably entails a number of side effects. For ease of understanding, they are classified by the mechanism of development:

  • Related to bradykinin. The accumulation of bradykinin in tissues causes irritation of respiratory tract receptors and debilitating dry cough. In more severe cases, excess bradykinin provokes the development of angioedema.
  • Related to aldosterone deficiency. A decrease in aldosterone levels naturally inhibits potassium excretion by the kidneys. This leads to the retention of the ion in the body and the development of hyperkalemia.
  • Other adverse events. Proteinuria (loss of protein in the urine) may be observed from the kidneys. The nervous system sometimes reacts with the appearance of headache and dizziness. Allergic manifestations in the form of skin rash are also possible.

Briefly: answers to topical questions

What are the absolute contraindications to taking captopril?

Absolute contraindications to prescribing ACE inhibitors, including captopril, are pregnancy, a history of angioedema, dry cough and allergic reactions to drugs of this group, as well as previously identified bilateral renal artery stenosis.

How to memorize

For quick memorization of the main side effects, use the acronym CAP: C — Cough (dry, due to bradykinin), A — Angioedema, P — Potassium elevation (hyperkalemia) and Proteinuria.

Class and exam questions

Why is it important to follow the administration schedule of captopril relative to food?

The presence of food in the gastrointestinal tract critically reduces the bioavailability of the drug. Absorption of the active substance decreases to 30–55%, which can nullify the entire antihypertensive effect.

How rapidly does the effect develop, and how long does it last?

The drug begins to work very rapidly — a decrease in blood pressure is noted as early as 30–60 minutes. However, this is a short-acting agent; its effect lasts only from 4 to 8 hours.

Why might a dry cough occur during treatment?

This side effect is directly related to the mechanism of action of the drug. Blockade of the enzyme leads to the accumulation of bradykinin in the respiratory tract, which causes irritation and a characteristic cough.

What is the risk of hyperkalemia associated with?

The drug causes a decrease in the level of aldosterone — a hormone that normally promotes potassium excretion. Under conditions of aldosterone deficiency, potassium begins to be retained in the body.

Something unclear? Ask the AIThe AI tutor has read the material on "Captopril" and will explain it in simple terms.

What else to study on this topic

  • Hemodynamic mechanisms of reducing myocardial preload and afterload.
  • Pathogenesis of the development of dry cough and angioedema against the background of bradykinin accumulation.
  • The relationship between aldosterone deficiency and the development of hyperkalemia.
  • Features of the pathogenesis and course of high-renin forms of arterial hypertension.
  • Causes of proteinuria during ACE inhibitor administration.

Master the entire topic in the «Pharmacology» course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Captopril" and another 5,304 subject pages
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 116 video lessons on the subject

Other topics in the section "Cardiovascular Drugs"

The entire section "Cardiovascular Drugs"

Free video lessons: pharmacologyShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.